# Ovarian Tumors — GCMD Library living collection Everything in the library about ovarian tumors — built automatically from dossiers that name it. Updated: n/a · 3 episodes · 91 cited statements ## Episodes ### Case-Based Learning - [Pediatric Ovarian Tumors Video Podcast](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362) — podcast · 34:06 · [machine version](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362.md) - [Ovarian Tumors Video Podcast](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979) — podcast · 34:06 · [machine version](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979.md) ### In-Depth Reviews - [Ovarian Tumors with Dr. Roshni Dasgupta](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829) — video · [machine version](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829.md) ## Chapters - [0:00](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=0) Introduction and rationale for discussing ovarian tumors (Ep 1) - [3:26](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=206) Case 1: 4-year-old with predominantly cystic mass with solid component (Ep 1) - [4:56](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=296) Overview of ovarian tumor types and epidemiology (Ep 1) - [7:30](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=450) Oncologic surgical principles and technique for tumor removal (Ep 1) - [11:26](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=686) Technical details of ovarian-sparing resection (Ep 1) - [14:55](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=895) Case 2: 13-year-old with large purely cystic mass (Ep 1) - [18:47](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1127) Case 3: Teenager with solid mass and elevated AFP (Ep 1) - [23:05](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1385) Staging procedures and chemotherapy indications (Ep 1) - [24:57](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1497) Management of ovarian torsion with possible tumor (Ep 1) - [29:32](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1772) Survival outcomes for malignant germ cell tumors (Ep 1) - [32:09](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1929) Final emphasis on ovarian preservation (Ep 1) - [0:00](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=0) Introduction and Episode Format (Ep 2) - [3:02](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=182) Case 1: Four-Year-Old with Mixed Cystic-Solid Mass (Ep 2) - [5:57](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=357) Surgical Approach for Case 1 (Ep 2) - [11:26](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=686) Technical Discussion of Surgical Techniques (Ep 2) - [14:55](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=895) Case 2: Thirteen-Year-Old with Large Cystic Mass (Ep 2) - [18:48](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1128) Case 3: Teenager with Solid Mass and Elevated AFP (Ep 2) - [23:12](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1392) Postoperative Management and Chemotherapy Indications (Ep 2) - [27:24](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1644) Management of Ovarian Torsion (Ep 2) - [29:33](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1773) Survival Outcomes for Malignant Germ Cell Tumors (Ep 2) - [32:09](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1929) Closing Emphasis on Ovarian Preservation (Ep 2) - [0:00](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=0) Introduction to ovarian pathology in pediatric surgery (Ep 3) - [0:55](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=55) Classification of neoplastic ovarian masses and genetic syndromes (Ep 3) - [2:36](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=156) Workup of an 8-year-old with palpable mass and precocious puberty (Ep 3) - [7:00](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=420) Germ cell tumor embryology and classification (Ep 3) - [10:44](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=644) Surgical staging and treatment of germ cell tumors (Ep 3) - [13:31](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=811) Chemotherapy for germ cell tumors and management of teratomas (Ep 3) - [17:23](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1043) Epithelial ovarian tumors: staging and fertility-sparing approaches (Ep 3) - [20:26](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1226) Summary of tumor markers and closing remarks (Ep 3) ## Statements Every statement is attributed, typed, and timestamped; the link is the citation. - "Predominantly cystic ovarian masses have approximately 3-4% malignancy risk" — Fred Rescorla (epidemiological) [Ep 2 · 4:03](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=243) - "Heterogeneous ovarian masses have 15-20% malignancy rate" — Fred Rescorla (epidemiological) [Ep 2 · 4:25](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=265) - "Solid ovarian masses have over 25% malignancy risk" — Fred Rescorla (epidemiological) [Ep 2 · 4:32](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=272) - "Approximately 10% or less of all pediatric ovarian tumors are malignant" — Fred Rescorla (epidemiological) [Ep 2 · 5:03](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=303) - "Among malignant pediatric ovarian tumors, germ cell tumors predominate at greater than 50%, possibly up to 80% in some series" — Fred Rescorla (epidemiological) [Ep 2 · 5:18](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=318) - "Among benign pediatric ovarian tumors, mature teratoma comprises at least half of cases" — Fred Rescorla (epidemiological) [Ep 2 · 5:43](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=343) - "Immature teratoma accounts for approximately 10-15% of benign ovarian tumors" — Fred Rescorla (epidemiological) [Ep 2 · 5:51](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=351) - "In a study of 20 stage III ovarian tumors, 5 were stage III only because peritoneal fluid was positive for malignant cells; without checking washings they would have been considered stage I with likely higher recurrence" — Fred Rescorla (host_summary) [Ep 2 · 8:10](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=490) - "For ovarian tumor surgery, six oncologic steps are recommended: peritoneal washings, tumor removal, contralateral ovary inspection (biopsy only if abnormal), omental assessment (remove if adherent to tumor), peritoneal cavity assessment for implants, and retroperitoneal lymph node palpation (remove only if enlarged)" — Fred Rescorla (guideline) [Ep 2 · 10:40](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=640) - "Contralateral ovarian biopsy is now recommended only if the ovary appears abnormal, not routinely" — Fred Rescorla (guideline) [Ep 2 · 10:54](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=654) - "For large predominantly cystic ovarian masses with normal markers, the malignancy risk is much less than 1%" — Fred Rescorla (epidemiological) [Ep 2 · 15:57](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=957) - "Pre-menarchal girls have a higher risk of ovarian torsion compared to post-menarchal adolescents" — Fred Rescorla (host_summary) [Ep 2 · 26:57](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1617) - "Oophoropexy is recommended for pre-menarchal girls with ovarian torsion or for patients with recurrent torsion of the same ovary" — Fred Rescorla (host_summary) [Ep 2 · 27:12](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1632) - "Stage I malignant germ cell ovarian tumors have 96% overall survival" — Fred Rescorla (epidemiological) [Ep 2 · 30:20](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1820) - "Stage I germ cell tumors managed with observation alone have approximately 50% relapse rate" — Fred Rescorla (epidemiological) [Ep 2 · 30:33](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1833) - "Salvage rate for relapsed stage I germ cell tumors is nearly 100%" — Fred Rescorla (epidemiological) [Ep 2 · 30:43](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1843) - "Stage II and III germ cell ovarian tumors have 97% survival with chemotherapy" — Fred Rescorla (epidemiological) [Ep 2 · 30:55](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1855) - "Stage IV germ cell ovarian tumors have approximately 80% overall survival" — Fred Rescorla (epidemiological) [Ep 2 · 31:15](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1875) - "Stage IV germ cell tumors in patients under 11 years have 92% survival" — Fred Rescorla (epidemiological) [Ep 2 · 31:23](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1883) - "Stage IV germ cell tumors in patients over 11 years have 60% survival" — Fred Rescorla (epidemiological) [Ep 2 · 31:33](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1893) - "Standard chemotherapy for intermediate-risk germ cell tumors is platinum, etoposide, and bleomycin" — Fred Rescorla (guideline) [Ep 2 · 32:00](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1920) - "Metastatic sites in stage IV germ cell tumors do not require biopsy if clearly metastatic on imaging; they are followed with imaging" — Fred Rescorla (clinical) [Ep 2 · 32:13](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1933) - "Black, torsed ovaries should not be removed; detorsion alone is appropriate" — Fred Rescorla (clinical) [Ep 2 · 32:32](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1952) - "Ovarian-preserving procedures (partial oophorectomy) are appropriate for cystic or mixed cystic-solid masses; oophorectomy is reserved for solid tumors" — Fred Rescorla (clinical) [Ep 2 · 32:44](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1964) - "Alpha-fetoprotein (AFP) is the primary tumor marker for pediatric ovarian tumors; HCG is unlikely to be elevated in young children but is checked routinely" — Fred Rescorla (clinical) [Ep 2 · 3:25](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=205) - "Chest CT is required for staging of malignant ovarian tumors and should be obtained preoperatively" — Fred Rescorla (guideline) [Ep 2 · 20:53](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1253) - "For malignant ovarian tumors amenable to resection, primary surgical resection is preferred even if metastases are present" — Fred Rescorla (clinical) [Ep 2 · 21:31](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1291) - "Fallopian tube preservation during oophorectomy is optional; the tube should be preserved if not encased by tumor but can be removed if adherent or difficult to separate" — Fred Rescorla (clinical) [Ep 2 · 21:42](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1302) - "Peritoneal washings are the main factor that can upstage an otherwise apparent stage I tumor to a higher stage" — Fred Rescorla (clinical) [Ep 2 · 22:48](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1368) - "Pediatric surgeons manage primarily germ cell tumors (chemo-responsive) while gynecologic oncologists manage primarily epithelial tumors, explaining differences in surgical approach including lymph node dissection" — Fred Rescorla (clinical) [Ep 2 · 23:20](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1400) - "Omental biopsy is not routine; omentum should be removed only if adherent to tumor or if abnormal on palpation" — Fred Rescorla (guideline) [Ep 2 · 24:07](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1447) - "Radiation therapy has no role in treatment of pediatric germ cell ovarian tumors" — Fred Rescorla (clinical) [Ep 2 · 24:16](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1456) - "Ovarian cryopreservation is not currently standard practice but may be considered in the future for patients receiving chemotherapy" — Fred Rescorla (opinion) [Ep 2 · 24:32](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1472) - "For acute ovarian torsion with unclear mass characteristics, detorsion can be performed and the ovary left in place with delayed resection after obtaining markers and better imaging" — Fred Rescorla (clinical) [Ep 2 · 26:57](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1617) - "A one-week delay for re-operation after detorsion makes no oncologic difference and allows for proper workup and ovarian-preserving surgery" — Fred Rescorla (clinical) [Ep 2 · 28:50](https://library.globalcastmd.com/watch/ovarian-tumors-video-podcast-1979?t=1730) - "Approximately 10% of pediatric ovarian tumors are malignant" — Fred Rescorla (epidemiological) [Ep 1 · 4:56](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=296) - "Among malignant ovarian tumors in children, germ cell tumors comprise greater than 50% and in some series up to 80%" — Fred Rescorla (epidemiological) [Ep 1 · 5:10](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=310) - "In benign ovarian tumors, mature teratoma represents at least half of cases" — Fred Rescorla (epidemiological) [Ep 1 · 5:30](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=330) - "Immature teratoma comprises approximately 10-15% of benign ovarian tumors" — Fred Rescorla (epidemiological) [Ep 1 · 5:45](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=345) - "Predominantly cystic ovarian masses have approximately 3-4% risk of malignancy" — Fred Rescorla (clinical) [Ep 1 · 4:20](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=260) - "Heterogeneous ovarian masses have approximately 15-20% malignancy risk" — Fred Rescorla (clinical) [Ep 1 · 4:35](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=275) - "Solid ovarian masses have over 25% malignancy risk" — Fred Rescorla (clinical) [Ep 1 · 4:45](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=285) - "In a study of stage 3 ovarian tumors with 20 patients, 5 were stage 3 only because peritoneal fluid was positive for malignant cells; without checking washings they would have been considered stage 1 with likely higher recurrence" — Fred Rescorla (host_summary) [Ep 1 · 8:10](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=490) - "For large predominantly cystic ovarian masses with normal markers, the risk of malignancy is much less than 1%" — Fred Rescorla (clinical) [Ep 1 · 15:50](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=950) - "There is no oncologic requirement to remove the fallopian tube with malignant ovarian tumors if it can be preserved" — Fred Rescorla (clinical) [Ep 1 · 21:44](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1304) - "CT scans are effective at detecting retroperitoneal lymph nodes and distant metastases in ovarian tumors" — Fred Rescorla (clinical) [Ep 1 · 22:29](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1349) - "Peritoneal washings are the main finding that can upstage an otherwise stage 1 ovarian tumor" — Fred Rescorla (clinical) [Ep 1 · 22:50](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1370) - "Pediatric surgeons deal primarily with germ cell tumors which are very chemo-responsive, while gynecologic surgeons deal more with epithelial tumors" — Fred Rescorla (clinical) [Ep 1 · 23:22](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1402) - "For ovarian germ cell tumors, chemotherapy consists of platinum-based regimen with platinum, etoposide, and bleomycin" — Fred Rescorla (clinical) [Ep 1 · 24:17](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1457) - "A recent study in Fertility and Sterility Journal demonstrated that premenarchal girls have higher risk of ovarian torsion" — Fred Rescorla (host_summary) [Ep 1 · 26:50](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1610) - "The recommendation from the Fertility and Sterility study is to perform oophoropexy in premenarchal girls or if the same ovary has torsed before" — Fred Rescorla (host_summary) [Ep 1 · 27:10](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1630) - "Stage 1 ovarian germ cell tumors have 96% overall survival" — Fred Rescorla (epidemiological) [Ep 1 · 30:10](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1810) - "Stage 1 ovarian germ cell tumors managed without chemotherapy have approximately 50% relapse rate" — Fred Rescorla (epidemiological) [Ep 1 · 30:20](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1820) - "The salvage rate for relapsed stage 1 ovarian germ cell tumors is nearly 100%" — Fred Rescorla (epidemiological) [Ep 1 · 30:40](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1840) - "Approximately 50% of stage 1 ovarian germ cell tumor patients receive no chemotherapy at all" — Fred Rescorla (epidemiological) [Ep 1 · 30:55](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1855) - "Stage 2 and 3 ovarian germ cell tumors have 97% survival with chemotherapy" — Fred Rescorla (epidemiological) [Ep 1 · 31:30](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1890) - "Stage 4 ovarian germ cell tumors have approximately 80% overall survival" — Fred Rescorla (epidemiological) [Ep 1 · 31:45](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1905) - "For stage 4 ovarian germ cell tumors, survival is approximately 92% if patient is less than 11 years of age" — Fred Rescorla (epidemiological) [Ep 1 · 31:55](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1915) - "For stage 4 ovarian germ cell tumors, survival is approximately 60% if patient is over 11 years of age" — Fred Rescorla (epidemiological) [Ep 1 · 31:55](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1915) - "Black, torsed ovaries should be detorsed and preserved rather than removed" — Fred Rescorla (clinical) [Ep 1 · 32:32](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1952) - "Ovarian-preserving procedures should be performed for cystic or cystic with small solid component masses; only solid tumors require oophorectomy" — Fred Rescorla (clinical) [Ep 1 · 32:45](https://library.globalcastmd.com/watch/pediatric-ovarian-tumors-video-podcast-362?t=1965) - "Neoplastic ovarian masses are classified into three types based on tissue of origin: epithelial ovarian tumors, stromal/sex cord tumors, and germ cell tumors (from the yolk sac)." — Roshni Dasgupta (clinical) [Ep 3 · 0:55](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=55) - "Malignancy from neoplastic ovarian processes is rare, making up only 2% of cancers in children overall." — Roshni Dasgupta (epidemiological) [Ep 3 · 1:35](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=95) - "Ovarian malignancy is more common in the 10-19 year age group and any malignant lesion under age 5 is reportable." — Roshni Dasgupta (clinical) [Ep 3 · 1:45](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=105) - "Peutz-Jeghers syndrome is associated primarily with granulosa cell tumors and sex cord tumors." — Roshni Dasgupta (clinical) [Ep 3 · 2:00](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=120) - "Ollier and Maffucci syndromes are associated with ovarian tumors." — Roshni Dasgupta (clinical) [Ep 3 · 2:10](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=130) - "Chediak-Higashi and McCune-Albright syndromes are also associated with ovarian tumors." — Roshni Dasgupta (clinical) [Ep 3 · 2:18](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=138) - "Workup for suspected ovarian tumor with precocious puberty includes renal panel, CBC, estradiol, progesterone, tumor markers, and ultrasound." — Roshni Dasgupta (clinical) [Ep 3 · 3:00](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=180) - "CT scan advantages for ovarian mass evaluation include better determination of tumor location and extent, and superior detection of calcifications compared to MRI." — Roshni Dasgupta (clinical) [Ep 3 · 3:50](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=230) - "CT scan disadvantage is radiation exposure to the child." — Roshni Dasgupta (clinical) [Ep 3 · 4:10](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=250) - "MRI provides better tissue detail, can help distinguish ovarian from parovarian masses, and is excellent at detecting lymph nodes." — Roshni Dasgupta (clinical) [Ep 3 · 4:18](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=258) - "MRI disadvantages include longer acquisition time (sometimes requiring anesthesia), reduced availability, and higher cost." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 4:34](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=274) - "Tumor markers commonly associated with ovarian tumors include AFP, beta-hCG, CA-125 (for epithelial tumors), inhibin A and B, hormones (estradiol, progesterone), LDH, CBC, and renal function tests." — Roshni Dasgupta (clinical) [Ep 3 · 5:01](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=301) - "Elevated inhibin B is associated with granulosa cell tumor, a sex cord tumor that causes virilizing effects." — Roshni Dasgupta (clinical) [Ep 3 · 5:40](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=340) - "CA-125 can be elevated in benign conditions such as endometriosis and other inflammatory conditions, sometimes to levels that overlap with malignancy." — Roshni Dasgupta (clinical) [Ep 3 · 6:34](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=394) - "Primordial germ cells form in the first week of gestation, and by week three they form the wall of the yolk sac and migrate along the mesentery of the hindgut." — Roshni Dasgupta (clinical) [Ep 3 · 7:15](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=435) - "Germ cell tumors can be gonadal (when germ cells migrate to the gonads) or extragonadal (sacrococcygeal teratomas, mediastinal lesions)." — Roshni Dasgupta (clinical) [Ep 3 · 7:45](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=465) - "Within gonadal germ cell tumors, if cells differentiate properly, extraembryonic differentiation produces choriocarcinomas and yolk sac tumors, while embryonic differentiation produces teratomas and mixed germ cell tumors." — Roshni Dasgupta (clinical) [Ep 3 · 8:10](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=490) - "If germ cells do not differentiate properly, they are classified as seminomas in boys and dysgerminomas in girls." — Roshni Dasgupta (clinical) [Ep 3 · 8:50](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=530) - "About 20% of germ cell tumors are malignant." — Roshni Dasgupta (epidemiological) [Ep 3 · 9:20](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=560) - "AFP is the primary tumor marker for germ cell disease." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 9:28](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=568) - "Dysgerminomas are the most common malignant histology, comprising 30% of germ cell tumors, and can be bilateral." — Roshni Dasgupta (epidemiological) [Ep 3 · 9:35](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=575) - "Dysgerminomas have a unique laboratory pattern: elevated LDH, but in a pure dysgerminoma AFP and beta-hCG can be normal; hypercalcemia may also be present." — Roshni Dasgupta (clinical) [Ep 3 · 9:48](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=588) - "Germ cell tumor staging requires peritoneal washings, examination of the entire peritoneal cavity, omental resection only if suspicious nodules are present, and unilateral salpingo-oophorectomy (salpingectomy only if fallopian tube is involved)." — Roshni Dasgupta (clinical) [Ep 3 · 11:12](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=672) - "For germ cell tumors, lymph nodes should be examined intraoperatively but only removed if enlarged or suspicious; standard lymph node dissection is not required." — Roshni Dasgupta (clinical) [Ep 3 · 11:12](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=672) - "Any portion of the ovary that can be preserved should be considered during germ cell tumor resection." — Roshni Dasgupta (clinical) [Ep 3 · 11:50](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=710) - "COG staging for germ cell tumors: stage I is limited to the ovary with negative washings; stage II includes capsular rupture with negative washings; stage III is lymph node involvement; stage IV is distant metastasis." — Roshni Dasgupta (guideline) [Ep 3 · 12:42](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=762) - "Stage I germ cell tumors can be managed with surgery alone and observation if the tumor is not ruptured." — Roshni Dasgupta (clinical) [Ep 3 · 13:31](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=811) - "If a germ cell tumor is ruptured during laparoscopic resection and tumor is spilled, the patient is required to receive chemotherapy." — Roshni Dasgupta (clinical) [Ep 3 · 14:00](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=840) - "PEB chemotherapy (platinum, etoposide, bleomycin) is the standard approach for germ cell tumors requiring adjuvant treatment and is very effective." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 14:42](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=882) - "Six-year overall survival with PEB chemotherapy is excellent even in stage IV germ cell tumor patients." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 15:05](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=905) - "Teratomas consist of all three primordial tissue types (ectoderm, mesoderm, endoderm) and can contain brain, bone, and teeth." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 15:20](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=920) - "Cystic teratomas are the most common type and can be bilateral in about 10% of patients." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 15:40](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=940) - "Calcifications are often visible in teratomas, making CT scan useful for detection." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 15:50](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=950) - "Immature teratomas have neuroepithelial components graded 0-3; higher grades are more likely to have yolk sac foci and malignant behavior." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 15:58](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=958) - "Most immature teratomas do not need chemotherapy after resection." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 16:20](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=980) - "For mature teratomas with a cystic component, it is safe to decompress the cyst first to improve access and increase chances of ovarian preservation." — Roshni Dasgupta (clinical) [Ep 3 · 16:30](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=990) - "The ovarian capsule does not need to be closed after shelling out a teratoma; there is no data showing closure is necessary and it will form by itself." — Roshni Dasgupta (clinical) [Ep 3 · 16:55](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1015) - "A plastic bowel bag can be glued to the ovarian mass and a needle inserted through it to avoid spillage during teratoma resection." — Roshni Dasgupta (clinical) [Ep 3 · 17:10](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1030) - "Spillage of teratoma contents can cause growing teratoma syndrome, where teratoma grows throughout the abdomen and is not responsive to chemotherapy." — Roshni Dasgupta (clinical) [Ep 3 · 17:23](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1043) - "Epithelial ovarian tumors account for about 20% of pediatric ovarian tumors, which is relatively rare compared to adults." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 18:06](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1086) - "Epithelial tumors are mucinous and serous; serous lesions are more commonly bilateral than mucinous." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 18:20](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1100) - "Staging for epithelial ovarian tumors requires pelvic washings, abdominal examination, omentectomy, primary tumor removal, and lymph node dissection." — Roshni Dasgupta (clinical) [Ep 3 · 18:31](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1111) - "For epithelial tumors, lymph node dissection boundaries are the pelvic iliacs to the renal artery (para-aortic nodes below the renals)." — Roshni Dasgupta (clinical) [Ep 3 · 18:55](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1135) - "About 30% of normal-appearing lymph nodes in epithelial ovarian cancer are positive on pathology, which will upstage the patient." — Roshni Dasgupta (epidemiological) [Ep 3 · 19:23](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1163) - "Borderline epithelial tumors are more common in children and have a better prognosis than invasive ovarian cancer." — Em Gootee or Todd Ponsky (host_summary) [Ep 3 · 19:40](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1180) - "Borderline epithelial tumors can recur, so patients require close serial follow-up over many years." — Roshni Dasgupta (clinical) [Ep 3 · 20:00](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1200) - "For borderline epithelial tumors, ovarian-sparing surgery can be performed initially, and if pathology confirms borderline tumor, the ovary can either be removed in a second operation or the patient can be watched with close surveillance." — Roshni Dasgupta (clinical) [Ep 3 · 20:26](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1226) - "There is no perfect tumor marker for ovarian masses; studies from the Midwest Pediatric Surgery Consortium show that a panel of tumor markers is helpful, but no single marker perfectly predicts malignancy." — Roshni Dasgupta (clinical) [Ep 3 · 21:00](https://library.globalcastmd.com/watch/ovarian-tumors-with-dr-roshni-dasgupta-5829?t=1260) ## Changelog - Sep 25: 3 items added automatically --- Educational content from recorded physician discussions — not medical advice. Cite the canonical URL or the ?t= deep link. Policy: https://library.globalcastmd.com/ai